|
 |
|
FDA Approves Merck's GARDASIL®*, the World's First and Only Cervical Cancer Vaccine
June 8, 2006 - Merck & Co., Inc. announced today the US Food and Drug Administration (FDA) approved GARDASIL® [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine], the first and only vaccine to prevent cervical cancer and vulvar and vaginal pre-cancers caused by HPV types 16 and 18 and to prevent low grade and pre-cancerous lesions and genital warts caused by HPV types 6, 11, 16 and 18. In the United States, approximately 10,000 women are diagnosed with cervical cancer every year, and an average of 10 women die each day from the disease.
GARDASIL is supplied in vials as well as in single-dose prefilled Luer Lock syringes pre-assembled with the UltraSafe Passive® delivery system from Safety Syringes, Inc. View the complete GARDASIL monograph by clicking here.
Watch the CNN.com™ video, which includes footage from the assembly line where prefilled syringes are assembled with the UltraSafe Passive® delivery system.
© Video copyrighted 2006 by Cable News Network (CNN), LP, LLLP, A Time Warner Company
Usage of this CNN material does not constitute an implied or express endorsement by CNN.
* Gardasil® is a Trademark of Merck & Co., Inc.
|
|
|
